ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 138 filers reported holding ARCELLX INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,759,768 | +12.8% | 216,270 | -0.6% | 0.02% | -20.0% |
| Q2 2023 | $6,881,587 | +39.2% | 217,634 | +35.6% | 0.02% | -66.2% |
| Q1 2023 | $4,943,249 | +880.7% | 160,443 | +886.1% | 0.07% | +722.2% |
| Q4 2022 | $504,045 | -63.2% | 16,270 | -77.7% | 0.01% | -65.4% |
| Q3 2022 | $1,370,000 | +197.2% | 73,003 | +186.3% | 0.03% | +100.0% |
| Q2 2022 | $461,000 | -60.4% | 25,498 | -69.3% | 0.01% | -58.1% |
| Q1 2022 | $1,163,000 | – | 82,965 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 3,946,630 | $141,605,084 | 72.57% |
| NEA Management Company, LLC | 3,745,262 | $134,380,001 | 10.38% |
| Paradigm Biocapital Advisors LP | 2,953,122 | $105,958,017 | 7.19% |
| Samsara BioCapital, LLC | 613,921 | $22,027,485 | 6.74% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,869,967 | $102,974,416 | 5.56% |
| Perceptive Advisors | 3,965,978 | $142,299,291 | 4.75% |
| Cormorant Asset Management, LP | 2,150,000 | $77,142,000 | 4.50% |
| Affinity Asset Advisors, LLC | 400,000 | $14,352,000 | 4.04% |
| Novo Holdings A/S | 1,075,000 | $38,571,000 | 2.85% |
| Soleus Capital Management, L.P. | 643,777 | $23,098,719 | 2.13% |